Clinical Trial Update: Rituximab in the First Episode of Paediatric Nephrotic Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating rituximab for first-episode steroid-sensitive nephrotic syndrome in pediatric patients; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Steroid-sensitive Nephrotic Syndrome

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Steroid-Sensitive Nephrotic Syndrome | Phase 3 | Status: NOT_YET_RECRUITING